Cantor Fitzgerald Upgrades Humana to Overweight, Raises Price Target to $460

Cantor Fitzgerald analyst Sarah James has upgraded Humana (NYSE: HUM) from Neutral to Overweight and increased the price target from $300 to $460. This upgrade reflects a positive outlook on the company's performance.